We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

1 hedge funds and large institutions have $52K invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 297 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 298 → 1 (-297)

100% less funds holding in top 10

Funds holding in top 10: 47 → 0 (-47)

100% less capital invested

Capital invested by funds: $10.8B → $52K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 297

Holders
1
Holders Change
-297
Holders Change %
-99.66%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-47
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
297
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
-$950M
2
PCM
Pentwater Capital Management
Florida
-$652M
3
State Street
State Street
Massachusetts
-$376M
4
YCMGA
York Capital Management Global Advisors
New York
-$327M
5
BIT
BlackRock Institutional Trust
California
-$317M
Name Holding Trade Value Shares
Change 		Change in
Stake
VFA
276
Virtus Fund Advisers
Connecticut
– -$225K -1,304 Closed
LIA
277
LS Investment Advisors
Michigan
– -$210K -1,215 Closed
OA
278
OFI Advisors
Pennsylvania
– -$205K -1,184 Closed
PNC Financial Services Group
279
PNC Financial Services Group
Pennsylvania
– -$191K -1,101 Closed
TRCT
280
Tower Research Capital (TRC)
New York
– -$144K -834 Closed
NCGI
281
Next Century Growth Investors
Minnesota
– -$98K -571 Closed
Creative Planning
282
Creative Planning
Kansas
– -$81K -470 Closed
RA
283
Rational Advisors
New York
– -$81K -469 Closed
MAM
284
Mizuho Asset Management
Japan
– -$72K -417 Closed
SEI Investments
285
SEI Investments
Pennsylvania
– -$70K -406 Closed
LTFS
286
Ladenburg Thalmann Financial Services
Florida
– -$52K -301 Closed
CLOS
287
Compagnie Lombard Odier SCmA
Switzerland
– -$45K -260 Closed
W
288
Wealthfront
California
– -$36K -207 Closed
FQ
289
First Quadrant
California
– -$35K -200 Closed
TCOV
290
Trust Company of Vermont
Vermont
– -$35K -200 Closed
SAMC
291
Shinko Asset Management Company
Japan
– -$34K -198 Closed
GAM
292
Gemmer Asset Management
California
– -$32K -187 Closed
CBOA
293
Commonwealth Bank of Australia
Australia
– -$17K -100 Closed
RIA
294
Regal Investment Advisors
Michigan
– -$9K -50 Closed
IPC
295
Independent Portfolio Consultants
Florida
– -$8K -45 Closed
WCBA
296
Weaver C. Barksdale & Associates
Tennessee
– -$5K -30 Closed
MAA
297
Managed Account Advisors
New Jersey
– -$5K -28 Closed
8 9 10 11
12

SLXP Hedge Fund Activity: Q2 2015 in Review

1 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2015, worth a combined $52K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 297 funds closed out of SLXP and 0 opened new positions — a net loss of 297 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Paulson & Co, exiting entirely with an estimated $950M sold.

  • 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2015, down from 298 in Q1 2015.
  • Funds reported $52K of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2015 and 297 closed out, a net change of -297 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q2 2015 was Paulson & Co, an estimated $950M sold.

Based on aggregated 13F filings for Q2 2015.